Galizia Danilo, Minei Silvia, Maldi Elena, Chilà Giovanna, Polidori Alessio, Merlano Marco Carlo
Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Post-Graduate School of Specialization in Medical Oncology, University of Bari 'A. Moro', 70120 Bari, Italy.
Biomedicines. 2022 Oct 7;10(10):2498. doi: 10.3390/biomedicines10102498.
Most head and neck squamous cell carcinomas (HNSCCs) are caused by lifestyle, such as cigarette smoking, or by viruses, such as human papillomavirus (HPV) and Epstein-Barr virus (EBV). HNSCC remains a clinical challenge, notwithstanding the improvements observed in the past years, involving surgery, radiotherapy, and chemotherapy. Recurrent/metastatic (R/M) disease represents an unmet clinical need. Immunotherapy has improved the prognosis of a small proportion of these patients, but most still do not benefit. In the last decade, several preclinical and clinical studies have explored the HNSCC tumor immune microenvironment (TIME), identifying important differences between smoking-associated and virus-associated HNSCCs. This review aims to present how different etiologies affect the HNSCC TIME, affecting immune escape mechanisms and sensitivity to immunotherapy.
大多数头颈部鳞状细胞癌(HNSCC)是由生活方式引起的,如吸烟,或由病毒引起的,如人乳头瘤病毒(HPV)和爱泼斯坦-巴尔病毒(EBV)。尽管在过去几年中,头颈部鳞状细胞癌在手术、放疗和化疗方面取得了进展,但它仍然是一个临床挑战。复发/转移性(R/M)疾病代表了尚未满足的临床需求。免疫疗法改善了一小部分这类患者的预后,但大多数患者仍然没有受益。在过去十年中,多项临床前和临床研究探索了头颈部鳞状细胞癌的肿瘤免疫微环境(TIME),确定了吸烟相关和病毒相关头颈部鳞状细胞癌之间的重要差异。本综述旨在介绍不同病因如何影响头颈部鳞状细胞癌的肿瘤免疫微环境,影响免疫逃逸机制和对免疫疗法的敏感性。